Early research (Phase 1)Ended earlyNCT01010542What this trial is testingStudy Evaluating Single Dose Of ILV-095 In Psoriasis SubjectsWho this might be right forPlaque Psoriasis Pfizer 39
Testing effectiveness (Phase 2)Study completedNCT01001468What this trial is testingStudy to Assess VB-201 in Patients With PsoriasisWho this might be right forActive Plaque Psoriasis Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Large-scale testing (Phase 3)Study completedNCT06588738What this trial is testingA Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001Who this might be right forPlaque Psoriasis Alumis Inc 862
Large-scale testing (Phase 3)Study completedNCT04673786What this trial is testingCompare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque PsoriasisWho this might be right forPsoriasis Celltrion 509
Testing effectiveness (Phase 2)Study completedNCT01283698What this trial is testingClinical Trial to Investigate Efficacy of LAS41004 in PsoriasisWho this might be right forPsoriasis Almirall, S.A. 20
Testing effectiveness (Phase 2)Study completedNCT02949388What this trial is testingEfficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Stable Plaque Psoriasis Innovation Pharmaceuticals, Inc. 199
Large-scale testing (Phase 3)Study completedNCT02471144What this trial is testingPediatric Study in Children and Adolescents With Severe Plaque PsoriasisWho this might be right forChronic Severe Plaque-type Psoriasis Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Study completedNCT05763082What this trial is testingBioequivalence Study of Two Treatments for the Treatment of Plaque PsoriasisWho this might be right forPlaque Psoriasis Padagis LLC 414
Large-scale testing (Phase 3)Looking for participantsNCT06425549What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis UCB Biopharma SRL 168
Early research (Phase 1)Study completedNCT03018509What this trial is testingStudy to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis SubjectsWho this might be right forPlaque PsoriasisPsoriasisSkin Diseases Akros Pharma Inc. 47
Post-approval studies (Phase 4)WithdrawnNCT05499416What this trial is testingEffect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic ArthritisWho this might be right forPsoriasis VulgarisActive Psoriatic Arthritis Innovaderm Research Inc.
Testing effectiveness (Phase 2)Study completedNCT01360944What this trial is testingExploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque TestWho this might be right forPsoriasis Almirall, S.A. 22
Large-scale testing (Phase 3)Study completedNCT03219437What this trial is testingA Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 104
Large-scale testing (Phase 3)Study completedNCT01729754What this trial is testingEvaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)Who this might be right forPlaque Psoriasis Sun Pharmaceutical Industries Limited 1,090
Large-scale testing (Phase 3)Active Not RecruitingNCT06945107What this trial is testingSwitching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody TherapyWho this might be right forPlaque Psoriasis Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 308
Large-scale testing (Phase 3)Study completedNCT02684357What this trial is testingBI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AbbVie 577
Large-scale testing (Phase 3)Study completedNCT03210259What this trial is testingThe VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 259
Large-scale testing (Phase 3)Not Yet RecruitingNCT07511647What this trial is testingClinical Study of QL2106 InjectionWho this might be right forPlaque Psoriasis Qilu Pharmaceutical Co., Ltd. 318
Large-scale testing (Phase 3)Active Not RecruitingNCT03451851What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric ParticipantsWho this might be right forPsoriasis Janssen Research & Development, LLC 120
Testing effectiveness (Phase 2)Ended earlyNCT02243787What this trial is testingSafety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Covagen 24